$BXP
BXP Inc Stock $bxp

$bxp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165642324000028 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$850.5M	$839.4M	$803.2M
YoY Change	4.08%	4.51%	6.48%
Cost Of Revenue	$335.4M	$324.5M	$303.2M
YoY Change	10.4%	7.01%	8.62%
Gross Profit	$515.1M	$515.0M	$491.0M
YoY Change	0.34%	4.88%	4.62%
Gross Profit Margin	60.56%	61.35%	61.13%
Selling, General & Admin	$44.11M	$50.02M	$55.80M
YoY Change	-0.15%	-10.37%	29.19%
% of Gross Profit	8.56%	9.71%	11.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$219.5M	$218.7M	$208.7M
YoY Change	8.37%	4.78%	17.51%
% of Gross Profit	42.62%	42.47%	42.51%
Operating Expenses	$263.7M	$268.7M	$264.5M
YoY Change	6.85%	1.59%	19.8%
Operating Profit	$251.4M	$246.2M	$226.5M
YoY Change	-5.69%	8.73%	-8.86%
Interest Expense	-$144.3M	-$125.5M	$134.2M
YoY Change	10.9%	-193.52%	32.58%
% of Operating Profit	-57.39%	-50.97%	59.26%
Other Income/Expense, Net			$0.00
YoY Change
Pretax Income	$106.9M	$106.6M	$105.6M
YoY Change	-21.47%	0.92%	-40.31%
Income Tax
% Of Pretax Income
Net Earnings	$79.62M	$79.88M	$77.89M
YoY Change	-23.67%	2.56%	-45.55%
Net Earnings / Revenue	9.36%	9.52%	9.7%
Basic Earnings Per Share	$0.51	$0.51	$0.50
Diluted Earnings Per Share	$0.51	$0.51	$0.50
COMMON SHARES
Basic Shares Outstanding	157.1M shares	157.0M shares	156.8M shares
Diluted Shares Outstanding	157.3M shares	157.1M shares	157.0M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$685.4M	$701.7M	$951.1M
YoY Change	-56.66%	-26.22%	101.36%
Cash & Equivalents	$685.4M	$701.7M	$919.0M
Short-Term Investments	$36.84M	$37.18M	$32.10M
Other Short-Term Assets	$86.19M	$146.3M	$141.9M
YoY Change	11.27%	3.07%	10.48%
Inventory
Prepaid Expenses
Receivables	$99.48M	$110.3M	$98.63M
Other Receivables	$1.415B	$1.390B	$1.298B
Total Short-Term Assets	$2.286B	$2.349B	$2.457B
YoY Change	-25.85%	-4.43%	31.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.79B	$20.77B	$19.54B
YoY Change	6.09%	6.29%	6.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.456B	$1.437B	$1.785B
YoY Change	-19.77%	-19.48%	14.8%
Other Assets	$852.2M	$883.4M	$765.5M
YoY Change	12.47%	15.4%	16.82%
Total Long-Term Assets	$23.19B	$23.18B	$22.17B
YoY Change	4.18%	4.55%	7.55%
TOTAL ASSETS
Total Short-Term Assets	$2.286B	$2.349B	$2.457B
Total Long-Term Assets	$23.19B	$23.18B	$22.17B
Total Assets	$25.47B	$25.53B	$24.63B
YoY Change	0.52%	3.66%	9.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$372.5M	$374.7M	$397.8M
YoY Change	-14.29%	-5.81%	30.61%
Accrued Expenses	$497.9M	$497.2M	$318.8M
YoY Change	57.62%	55.96%	7.88%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0M	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.543B	$1.044B	$888.1M
YoY Change	67.32%	17.57%	15.19%
LONG-TERM LIABILITIES
Long-Term Debt	$15.24B	$15.78B	$14.96B
YoY Change	-2.96%	5.47%	12.86%
Other Long-Term Liabilities	$406.4M	$426.1M	$470.9M
YoY Change	-4.39%	-9.5%	15.6%
Total Long-Term Liabilities	$15.65B	$16.20B	$15.43B
YoY Change	-3.0%	5.01%	12.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.543B	$1.044B	$888.1M
Total Long-Term Liabilities	$15.65B	$16.20B	$15.43B
Total Liabilities	$19.67B	$19.67B	$16.31B
YoY Change	1.92%	20.57%	13.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$964.5M	-$890.2M	-$467.2M
YoY Change	86.72%	90.55%	-26.6%
Common Stock	$1.571M	$1.570M	$1.568M
YoY Change	0.13%	0.13%	0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.722M	$2.722M	$2.722M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares			78.90K shares
Shareholders Equity	$5.803B	$5.858B	$6.063B
YoY Change
Total Liabilities & Shareholders Equity	$25.47B	$25.53B	$24.63B
YoY Change	0.52%	3.66%	9.56%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$79.62M	$79.88M	$77.89M
YoY Change	-23.67%	2.56%	-45.55%
Depreciation, Depletion And Amortization	$219.5M	$218.7M	$208.7M
YoY Change	8.37%	4.78%	17.51%
Cash From Operating Activities	$367.1M	$197.6M	$234.0M
YoY Change	-3.19%	-15.56%	6.62%
INVESTING ACTIVITIES
Capital Expenditures	$231.1M	$267.1M	$226.0M
YoY Change	3.44%	18.21%	-221.57%
Acquisitions		-$6.086M	$0.00
YoY Change
Other Investing Activities	-$35.74M	-$19.52M	-$59.64M
YoY Change	-21.99%	-67.27%	-272.67%
Cash From Investing Activities	-$266.9M	-$286.6M	-$285.6M
YoY Change	-0.89%	0.36%	88.72%
FINANCING ACTIVITIES
Cash Dividend Paid		$171.8M	$171.3M
YoY Change		0.31%	0.46%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-129.3M	-$756.9M	$279.1M
YoY Change	-123.33%	-371.24%	-420.86%
NET CHANGE
Cash From Operating Activities	367.1M	$197.6M	$234.0M
Cash From Investing Activities	-266.9M	-$286.6M	-$285.6M
Cash From Financing Activities	-129.3M	-$756.9M	$279.1M
Net Change In Cash	-29.13M	-$845.9M	$227.5M
YoY Change	-104.39%	-471.89%	-1308.98%
FREE CASH FLOW
Cash From Operating Activities	$367.1M	$197.6M	$234.0M
Capital Expenditures	$231.1M	$267.1M	$226.0M
Free Cash Flow	$135.9M	-$69.51M	$8.053M
YoY Change	-12.71%	-963.09%	-98.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	415888000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	417961000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	377667000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	350391000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	374681000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	458329000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	172154000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	171176000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	119573000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	133684000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	417978000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	445947000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	17240265000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	17833785000	usd
CY2024Q1	us-gaap	Temporary Equity Shares Subscribed But Unissued TemporaryEquitySharesSubscribedButUnissued	124656	shares
CY2023Q4	us-gaap	Temporary Equity Shares Subscribed But Unissued TemporaryEquitySharesSubscribedButUnissued	119471	shares
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8141000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8383000	usd
CY2024Q1	bxp	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2023Q4	bxp	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	0	shares
CY2024Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	0	shares
CY2024Q1	bxp	Excess Stock Value ExcessStockValue	0	usd
CY2023Q4	bxp	Excess Stock Value ExcessStockValue	0	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157128071	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157019766	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157049171	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156940866	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1570000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1569000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6752648000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6715149000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-890177000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-816152000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	78900	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	78900	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2722000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2722000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3620000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21147000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5857699000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5876697000	usd
CY2024Q1	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	684969000	usd
CY2023Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	666580000	usd
CY2024Q1	us-gaap	Minority Interest In Limited Partnerships MinorityInterestInLimitedPartnerships	1734904000	usd
CY2023Q4	us-gaap	Minority Interest In Limited Partnerships MinorityInterestInLimitedPartnerships	1640704000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8277572000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8183981000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25525978000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26026149000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	788590000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	756875000	usd
CY2024Q1	us-gaap	Revenues Revenues	839439000	usd
CY2023Q1	us-gaap	Revenues Revenues	803200000	usd
CY2024Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	314157000	usd
CY2023Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	291308000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50018000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55802000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	513000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	911000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	218716000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	208734000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	593712000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	568661000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19186000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7569000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	14529000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	10941000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	2272000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	1665000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	396000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	259000	usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	13615000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	161891000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	134207000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	106604000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	105628000	usd
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Limited Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossLimitedPartnershipsNonredeemable	17221000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Limited Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossLimitedPartnershipsNonredeemable	18660000	usd
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	9500000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	9078000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	79883000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	77890000	usd
CY2024Q1	bxp	Earnings Per Share After Allocation Of Undistributed Earnings To Participating Securities Basic Dollars Per Share EarningsPerShareAfterAllocationOfUndistributedEarningsToParticipatingSecuritiesBasicDollarsPerShare	0.51
CY2023Q1	bxp	Earnings Per Share After Allocation Of Undistributed Earnings To Participating Securities Basic Dollars Per Share EarningsPerShareAfterAllocationOfUndistributedEarningsToParticipatingSecuritiesBasicDollarsPerShare	0.50
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156983000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156803000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157132000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157043000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	106604000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	105628000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	16351000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6538000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Hedge Gains AmortizationOfDeferredHedgeGains	-3360000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Hedge Gains AmortizationOfDeferredHedgeGains	-1675000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19711000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4863000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	126315000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	100765000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	26721000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27738000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	2184000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-368000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	97410000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	73395000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8183981000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2024Q1	bxp	Equity Profit Loss EquityProfitLoss	106604000	usd
CY2024Q1	us-gaap	Dividends Dividends	172772000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	600000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16531000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	142942000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	20025000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	16351000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	3360000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8277572000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8363819000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2023Q1	bxp	Equity Profit Loss EquityProfitLoss	105628000	usd
CY2023Q1	us-gaap	Dividends Dividends	172054000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	586000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27419000	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	7555000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	21606000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-6538000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1675000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8306484000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	106604000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	105628000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	218716000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	208734000	usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	13615000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1441000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	652000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	18873000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	26262000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19186000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7569000	usd
CY2024Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	8643000	usd
CY2023Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5996000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	2272000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1665000	usd
CY2024Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4000	usd
CY2023Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	45000	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	12109000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	7387000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	396000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	259000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-29454000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7518000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	35945000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	18619000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	74705000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	97762000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-750000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	0	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1241000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	251000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-20725000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8505000	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-14171000	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	10626000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-12846000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	16565000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	29627000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	35911000	usd
CY2024Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	90991000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	128382000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	197595000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	234010000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	181636000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	119682000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	32087000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	39100000	usd
CY2024Q1	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	53377000	usd
CY2023Q1	us-gaap	Payments For Tenant Improvements PaymentsForTenantImprovements	67175000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-6086000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	26457000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	60745000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	733000	usd
CY2024Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	573000	usd
CY2023Q1	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-1425000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-1843000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-286619000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-285592000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	804000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	700000000	usd
CY2023Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1200000000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-3160000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	730000000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	108000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6213000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-2136000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	586000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	171794000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	171270000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	20025000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	21606000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-756909000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	279052000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-845933000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	227470000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1612567000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	736812000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	766634000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	964282000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1531477000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	690333000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	81090000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	46479000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	701695000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	918952000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	64939000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	45330000	usd
CY2024Q1	us-gaap	Interest Paid InterestPaid	180717000	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	125698000	usd
CY2024Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	9381000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	10589000	usd
CY2024Q1	bxp	Writeoffoffullydepreciatedrealestate Writeoffoffullydepreciatedrealestate	27993000	usd
CY2023Q1	bxp	Writeoffoffullydepreciatedrealestate Writeoffoffullydepreciatedrealestate	56391000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-48518000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11692000	usd
CY2024Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	25637000	usd
CY2023Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	usd
CY2024Q1	us-gaap	Contribution Of Property ContributionOfProperty	52786000	usd
CY2023Q1	us-gaap	Contribution Of Property ContributionOfProperty	0	usd
CY2024Q1	bxp	Capitalized Operating Lease Costs CapitalizedOperatingLeaseCosts	7548000	usd
CY2023Q1	bxp	Capitalized Operating Lease Costs CapitalizedOperatingLeaseCosts	0	usd
CY2024Q1	bxp	Investment In Unconsolidated Joint Ventures Eliminated Upon Consolidation InvestmentInUnconsolidatedJointVenturesEliminatedUponConsolidation	-11834000	usd
CY2023Q1	bxp	Investment In Unconsolidated Joint Ventures Eliminated Upon Consolidation InvestmentInUnconsolidatedJointVenturesEliminatedUponConsolidation	0	usd
CY2024Q1	us-gaap	Loans Assumed1 LoansAssumed1	207093000	usd
CY2023Q1	us-gaap	Loans Assumed1 LoansAssumed1	0	usd
CY2024Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	-220015000	usd
CY2023Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	172154000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	171427000	usd
CY2024Q1	bxp	Conversions Of Noncontrolling Interests To Stockholders Equity ConversionsOfNoncontrollingInterestsToStockholdersEquity	1303000	usd
CY2023Q1	bxp	Conversions Of Noncontrolling Interests To Stockholders Equity ConversionsOfNoncontrollingInterestsToStockholdersEquity	195000	usd
CY2024Q1	bxp	Issuance Of Restricted Securities To Employees And Directors IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors	41989000	usd
CY2023Q1	bxp	Issuance Of Restricted Securities To Employees And Directors IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors	46516000	usd
CY2024Q1	bxp	Restriction On Redemption Of Op Units From Date Of Issuance In Years RestrictionOnRedemptionOfOpUnitsFromDateOfIssuanceInYears	1	y
CY2024Q1	bxp	Op Unit Conversion Rate OpUnitConversionRate	1	shares
CY2024Q1	bxp	Common Stock Conversion Rate CommonStockConversionRate	1	shares
CY2024Q1	bxp	Op Unit Conversion Rate OpUnitConversionRate	1	shares
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company bases its estimates on historical experience and on various other assumptions that it considers to be reasonable under the circumstances, including the impact of extraordinary events such as a pandemic, the results of which form the basis for making significant judgments about the carrying values of assets and liabilities, assessments of future collectability, and other areas of the financial statements that are impacted by the use of estimates. Actual results may differ from these estimates under different assumptions or conditions.</span></div>
CY2024Q1	us-gaap	Land Available For Development LandAvailableForDevelopment	661713000	usd
CY2023Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	697061000	usd
CY2024Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	16689571000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	16607756000	usd
CY2024Q1	bxp	Numberof Vi Es NumberofVIEs	9
CY2024Q1	bxp	Separate Unrestricted Cash For Deferred Compensation Plan SeparateUnrestrictedCashForDeferredCompensationPlan	37000000	usd
CY2023Q4	bxp	Separate Unrestricted Cash For Deferred Compensation Plan SeparateUnrestrictedCashForDeferredCompensationPlan	36100000	usd
CY2024Q1	us-gaap	Land Land	5317032000	usd
CY2023Q4	us-gaap	Land Land	5251224000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	401486000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	401680000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	344255000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	324298000	usd
CY2024Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3654576000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3592172000	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	54691000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	53716000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	685465000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	547280000	usd
CY2024Q1	bxp	Real Estate Investment Property At Cost Including Rightof Use Assets RealEstateInvestmentPropertyAtCostIncludingRightofUseAssets	27808789000	usd
CY2023Q4	bxp	Real Estate Investment Property At Cost Including Rightof Use Assets RealEstateInvestmentPropertyAtCostIncludingRightofUseAssets	27475187000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	7040501000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	6881728000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	20768288000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	20593459000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	648890000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	621646000	usd
CY2024Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	139458000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	135003000	usd
CY2024Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	242000	usd
CY2023Q1	us-gaap	Sales Type Lease Revenue SalesTypeLeaseRevenue	226000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	788590000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	756875000	usd
CY2024Q1	bxp	Amount Of Earthquake Insurance Provided By Ixpllc As Direct Insurer San Franciscoand Los Angeles AmountOfEarthquakeInsuranceProvidedByIXPLLCAsDirectInsurerSanFranciscoandLosAngeles	30000000	usd
CY2024Q1	bxp	Earthquake Deductible Insurance Percentage Of Value Of The Affected Property San Franciscoand Los Angeles EarthquakeDeductibleInsurancePercentageOfValueOfTheAffectedPropertySanFranciscoandLosAngeles	0.05
CY2024Q1	bxp	Per Occurrence Limit Of Earthquake Insurance Seattle PerOccurrenceLimitOfEarthquakeInsuranceSeattle	110000000	usd
CY2024Q1	bxp	Annual Aggregate Limit Of Earthquake Insurance Seattle AnnualAggregateLimitOfEarthquakeInsuranceSeattle	110000000	usd
CY2024Q1	bxp	Earthquake Deductible Insurance Percentage Of Value Of The Affected Property Seattle EarthquakeDeductibleInsurancePercentageOfValueOfTheAffectedPropertySeattle	0.02
CY2023Q1	bxp	Rental Revenue Total RentalRevenueTotal	788985000	usd
CY2023Q1	bxp	Percentage Of Total Revenue PercentageOfTotalRevenue	1.0000
CY2024Q1	bxp	Investments In Affiliates Subsidiaries Associates And Joint Venturesnet InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesnet	1370447000	usd
CY2023Q4	bxp	Investments In Affiliates Subsidiaries Associates And Joint Venturesnet InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesnet	1337416000	usd
CY2024Q1	bxp	Schedule Of Statements Of Operations Of Unconsolidated Joint Ventures Text Bock ScheduleOfStatementsOfOperationsOfUnconsolidatedJointVenturesTextBock	<div style="margin-top:20pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combined summarized statements of operations of the Company’s unconsolidated joint ventures are as follows:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.375%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (1)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,392 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,206 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,424 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,978 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,620 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,258 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,112 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,321 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,695)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company’s share of net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale / consolidation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,696 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differential (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(667)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from unconsolidated joint ventures</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,186 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,569)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________ </span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes straight-line rent adjustments of approximately $7.7 million and $6.3 million for the three months ended March 31, 2024 and 2023, respectively. </span></div><div style="padding-left:27pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.02pt">Includes depreciation and amortization of approximately $2.9 million and $3.7 million for the three months ended March 31, 2024 and 2023, respectively. Includes unrealized gain (loss) on derivative instruments of approximately $2.7 million and $(2.8) million for the three months ended March 31, 2024 and 2023, respectively. Includes straight-line rent adjustments of approximately $0.3 million for the three months ended March 31, 2024 and 2023. Also includes net above-/below-market rent adjustments of approximately $0.2 million for the three months ended March 31, 2024 and 2023.</span></div>
CY2023Q4	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	600000000	usd
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Oci FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci	16351000	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Oci FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossOci	-6538000	usd
CY2024Q1	us-gaap	Derivative Instruments Gain Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	3360000	usd
CY2023Q1	us-gaap	Derivative Instruments Gain Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	1675000	usd
CY2024Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2023Q1	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2024Q1	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	0	usd
CY2024Q1	bxp	Letter Of Credit And Performance Obligation LetterOfCreditAndPerformanceObligation	21600000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1500000	usd
CY2024Q1	us-gaap	Loss Contingency Range Of Possible Loss Portion Not Accrued LossContingencyRangeOfPossibleLossPortionNotAccrued	31000000	usd
CY2024Q1	bxp	Insurance Policy Limit InsurancePolicyLimit	1000000000	usd
CY2024Q1	bxp	Insurance Policy Limit InsurancePolicyLimit	1000000000	usd
CY2024Q1	bxp	Per Occurrence Limit For Nbcr Coverage PerOccurrenceLimitForNbcrCoverage	1000000000	usd
CY2024Q1	bxp	Program Trigger Value ProgramTriggerValue	200000000	usd
CY2024Q1	bxp	Program Trigger Coinsurance ProgramTriggerCoinsurance	0.20
CY2024Q1	bxp	Programtriggerdeductible Programtriggerdeductible	0.20
CY2024Q1	bxp	Per Occurrence Limit Of Earth Quake Insurance San Franciscoand Los Angeles PerOccurrenceLimitOfEarthQuakeInsuranceSanFranciscoandLosAngeles	330000000	usd
CY2024Q1	bxp	Annual Aggregate Limit Of Earth Quake Insurance San Franciscoand Los Angeles AnnualAggregateLimitOfEarthQuakeInsuranceSanFranciscoandLosAngeles	330000000	usd
CY2024Q1	us-gaap	Minority Interest In Limited Partnerships MinorityInterestInLimitedPartnerships	1700000000	usd
CY2023Q4	us-gaap	Minority Interest In Limited Partnerships MinorityInterestInLimitedPartnerships	1600000000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157049171	shares
CY2024Q1	us-gaap	General Partners Capital Account Units Outstanding GeneralPartnersCapitalAccountUnitsOutstanding	1762080	shares
CY2024Q1	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	155287091	shares
CY2024Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	36305	shares
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.98
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.98
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.98
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.98
CY2024Q1	bxp	Rental Revenue Class Office RentalRevenueClassOffice	808122000	usd
CY2024Q1	bxp	Rental Revenue Residential RentalRevenueResidential	12684000	usd
CY2024Q1	bxp	Rental Revenue Total RentalRevenueTotal	828992000	usd
CY2024Q1	bxp	Percentage Of Total Revenue PercentageOfTotalRevenue	1.0000
CY2024Q1	bxp	Rental Expenses Class Office RentalExpensesClassOffice	308471000	usd
CY2024Q1	bxp	Rental Expenses Residential RentalExpensesResidential	5686000	usd
CY2024Q1	bxp	Rental Expenses Operating Expenses Total RentalExpensesOperatingExpensesTotal	320172000	usd
CY2024Q1	bxp	Percentage Of Total Rental Expenses PercentageOfTotalRentalExpenses	1.0000
CY2024Q1	us-gaap	Gross Profit GrossProfit	508820000	usd
CY2024Q1	bxp	Percentage Of Total Net Operating Income PercentageOfTotalNetOperatingIncome	1.0000
CY2024Q1	bxp	Percentageof Companys Shareof Net Operating Income PercentageofCompanysShareofNetOperatingIncome	1.0000
CY2023Q1	bxp	Rental Revenue Class Office RentalRevenueClassOffice	769158000	usd
CY2023Q1	bxp	Rental Revenue Residential RentalRevenueResidential	11726000	usd
CY2023Q1	bxp	Rental Expenses Class Office RentalExpensesClassOffice	285845000	usd
CY2023Q1	bxp	Rental Expenses Residential RentalExpensesResidential	5463000	usd
CY2023Q1	bxp	Rental Expenses Operating Expenses Total RentalExpensesOperatingExpensesTotal	297979000	usd
CY2023Q1	bxp	Percentage Of Total Rental Expenses PercentageOfTotalRentalExpenses	1.0000
CY2023Q1	us-gaap	Gross Profit GrossProfit	491006000	usd
CY2023Q1	bxp	Percentage Of Total Net Operating Income PercentageOfTotalNetOperatingIncome	1.0000
CY2023Q1	bxp	Percentageof Companys Shareof Net Operating Income PercentageofCompanysShareofNetOperatingIncome	1.0000
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	79883000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156983000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2024Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	149000	shares
CY2024Q1	bxp	Weighted Average Number Diluted Shares Outstanding Adjustmentpershare WeightedAverageNumberDilutedSharesOutstandingAdjustmentpershare	0
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	79883000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157132000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	77890000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156803000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
CY2023Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	240000	shares
CY2023Q1	bxp	Weighted Average Number Diluted Shares Outstanding Adjustmentpershare WeightedAverageNumberDilutedSharesOutstandingAdjustmentpershare	0
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	77890000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	157043000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.50
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18500000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25900000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001656423-24-000028-index-headers.html	Edgar Link	pending
0001656423-24-000028-index.html	Edgar Link	pending
0001656423-24-000028.txt	Edgar Link	pending
0001656423-24-000028-xbrl.zip	Edgar Link	pending
bxp-20240331.htm	Edgar Link	pending
bxp-20240331.xsd	Edgar Link	pending
bxpbplp-20243311ex321.htm	Edgar Link	pending
bxpbplp-2024331ex311.htm	Edgar Link	pending
bxpbplp-2024331ex312.htm	Edgar Link	pending
bxpbplp-2024331ex313.htm	Edgar Link	pending
bxpbplp-2024331ex314.htm	Edgar Link	pending
bxpbplp-2024331ex322.htm	Edgar Link	pending
bxpbplp-2024331ex323.htm	Edgar Link	pending
bxpbplp-2024331ex324.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
bxp-20240331_lab.xml	Edgar Link	unprocessable
bxp-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bxp-20240331_pre.xml	Edgar Link	unprocessable
bxp-20240331_htm.xml	Edgar Link	completed
bxp-20240331_def.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BXP
BXP Inc Stock $bxp

2024 Q2 Form 10-Q Financial Statement

#000165642324000028 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BXP BXP Inc Stock $bxp

2024 Q2 Form 10-Q Financial Statement

#000165642324000028 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BXP
BXP Inc Stock $bxp